Analyst Ranking
Top 18%
#1008 out of 5558 analysts
Average Return
+13.01%
Win Rate
45%27 out of 60
Risk vs Reward
Poor
Good

Uy Ear's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Mbx Biosciences IncMBX
+491.63%$11.95$70.70
2025-08-05 -
2026-08-04
Buy
Arcutis Biotherapeutics IncARQT
+306.12%$3.43$13.93
2024-01-02 -
2024-12-31
Strong Buy
Arcutis Biotherapeutics IncARQT
+272.38%$3.91$14.56
2024-01-03 -
2025-01-02
Strong Buy
Mbx Biosciences IncMBX
+188.01%$20.10$57.89
2025-09-24 -
2026-09-23
Buy
Cabaletta Bio IncCABA
+131.36%$8.10$18.74
2023-03-17 -
2024-03-15
Strong Buy

Uy Ear Analyst Color

Get additional color on Uy Ear's coverage of popular stocks

Uy Ear's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mbx Biosciences IncMBX
3Buy$91.00+62.67%Maintains
4 months ago
Alkermes PLCALKS
7Buy$65.00+38.21%Maintains
4 months ago
Uniqure NvQURE
9Buy$68.00+185.59%Maintains
5 months ago
Sol Gel Technologies LtdSLGL
1Buy$285.00+417.05%Initiates Coverage On
5 months ago
Relmada Therapeutics IncRLMD
3Buy$19.00+351.31%Maintains
8 months ago
Sarepta Therapeutics IncSRPT
9Buy$31.00+92.91%Maintains
8 months ago
Arcutis Biotherapeutics IncARQT
15Buy$35.00+23.85%Maintains
9 months ago
Acadia Pharmaceuticals IncACAD
16Buy$35.00+86.67%Upgrades
9 months ago
Neurocrine Biosciences IncNBIX
10Hold$175.00+4.54%Maintains
a year ago
Evolus IncEOLS
4Buy$19.00+172.99%Maintains
a year ago
Tectonic Therapeutic IncTECX
6Buy$85.00N/AMaintains
2 years ago
Sage Therapeutics IncSAGE
2Hold$16.00N/AMaintains
2 years ago
Cartesian Therapeutics IncRNAC
3Strong Buy$40.00N/AInitiates Coverage On
2 years ago
Revance Therapeutics IncRVNC
1Strong Buy$16.00N/AMaintains
3 years ago
Johnson & JohnsonJNJ
1Strong Buy$40.00N/AMaintains
3 years ago
Satsuma Pharmaceuticals IncSTSA
1Hold$2.00N/AReiterates
4 years ago
Cabaletta Bio IncCABA
1Strong Buy$10.00N/AReiterates
4 years ago
Ocugen IncOCGN
2Strong Buy$3.00N/AMaintains
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.